-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Privia Health Gr, Raises Price Target to $34

Benzinga·11/12/2025 13:06:33
Listen to the news
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $32 to $34.